InvestorsHub Logo
Followers 74
Posts 7486
Boards Moderated 0
Alias Born 04/18/2006

Re: Jimmy Quick post# 102524

Tuesday, 10/02/2018 5:03:22 PM

Tuesday, October 02, 2018 5:03:22 PM

Post# of 196263
$RXMD = GREAT INVESTMENT, OVER 20 MILLION REVS
RXMD IS ON A COURSE FOR SUCCESS, ON OTCQB and NASDAQ


OUTLOOK FOR 2018: Completion of TWO REVENUE PRODUCING ACQUISTIONS (TouchPointRX Complete)
OUTLOOK FOR 2019: SEC Reporting Compliance, NASDAQ Uplist, and more ACQUISITIONS

ALL POINTS TO CONTINUED DEVELOPMENT AND GROWTH THROUGH EXPANSION ****INVEST WISELY****

WITH EXTREMELY LOW SHARE STRUCTURE
RXMD Security Details
Share Structure
Authorized Shares
500,000,000 08/31/2018
Outstanding Shares
431,221,376 on 08/31/2018 This balance also includes 5,590,432 common shares that were beneficially owned by Progressive Care through PharmCo, LLC and Progressive Training, Inc. and will be retired back to Treasury. So actual amount is 425,630,944 Outstanding on F/S
Previously 428,997,097 on 7/17/18
Restricted
82,224,982 08/31/2018
Unrestricted
348,996,394 08/31/2018
Float
334,506,590 03/31/2018

SHORT TERM PRICE TARGET $.35
https://finance.yahoo.com/news/seethruequity-issues-progressive-care-inc-131500911.html
http://www.seethruequity.com/wp-content/uploads/2018/03/RXMD-UPDATE-MAR-9-2018-FINAL.pdf
[/color]

***THE REAL DEAL***
TWO REAL BRICK AND MORTAR LOCATIONS SERVICING:
MIAMI DADE COUNTY, FLORIDA
MARTIN COUNTY, FLORIDA
PALM BEACH COUNTY, FLORIDA
BROWARD COUNTY, FLORIDA
ST. LUCIE COUNTY, FLORIDA
70 Employees
2 YEARS AUDITED FINANCIAL STATEMENTS
OTCQB with INDEPENDENT BOARD and AUDIT COMMITTEE MEMBERS

HERES SOME JUICY 2018 NUMBERS - W NEW LOCATION ACQUIRED 3/30/18, these revenues will start to be recognized July 1, 2018
Scripts: 187,877 a 8.7% increase compared to August 31, 2017
Net Revenue: $14.1 million, a $565,000+ increase compared to August 31, 2017
340B Sales: $3.8 million, a $2.2 million+ increase compared to August 31, 2017
Annualized, 2018 340B Sales are estimated at $6.1 Million, that's a 120% increase over 2017's $2.75 Million. PharmCoRX is obviously increasing the number of customers.



Then let’s observe increase in revenue last year. JUST KEEPS INCREASING YOY

Then check out increase in revenue from the last 2 years.

Overall
G - FY 2013 = $9.3 million
R - FY 2014 = $11.3 million
O - FY 2015 = $13.7 million
W - FY 2016 = $18.3 million (AUDITED)
T - FY 2017 = $20.1 million (AUDITED) does not include 340B revenues of $2.75 million
H - FY 2018 = $14.1 million (8 months) does not include 340B revenues of $3.8 million


LET'S TALK ABOUT INCOME FROM PREVIOUS YEARS
Shall We . . .
FY 2017 = AUDITED Net Income, and w/o Discontinued Operations Net Income is $139,251
FY 2016 = AUDITED Net Income, and w/o Discontinued Operations Net Income is $259,319
Yes it did go down by $120,000, but quite explainable with information detailed below and still extraordinary when you consider the improvement from 2015 and 2014,
FY 2015 = $(1,219,000) Net Loss
FY 2014 = $(1,009,000) Net Loss

Expenses effecting additional net income has been applied to development, growth, and expansion initiatives. Growing, Growing, Growing. Everything says they are using money to GROW.


Available Cash Is Building Up !!!
End Of 2017 = $419,000 2nd Qtr 2018 = $705,890
FY 2017 A/R = $1,270,114 2nd Qtr 2018 = $ 1,165,855
Cash and A/R Combined Cash Assets
December 31, 2017 = $1,689,000
June, 2018 = $1,871,745


[color=blue]EVERYTHING IS MOVING FORWARDS AND LOOKING GREAT !!!
Another Acquisition Scheduled for 2018
Another Acquisition, SEC Reporting Compliance, and NASDAQ Uplifting for early 2019

"To Give Anything Less Than Your Best, Is To Sacrifice the Gift." - Steve Prefontaine
Selling shares at $.019 prior to run to $.26 would have been my biggest failure. Glad it wasn't me!! ;-)

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.